Zhong Guo Zheng Quan Bao·2025-11-04 20:17Core Points - The company has elected Chen Junze as an independent director and adjusted the specialized committees within the board [1][2][3] - Chen Junze's qualifications and independence have been verified and approved by the Shanghai Stock Exchange [2][3] - The company has recently obtained medical device registration certificates for several products, enhancing its product offerings [3][5] Group 1: Board Changes - Independent director Li Bo resigned due to personal work reasons [1] - Chen Junze has been nominated as an independent director candidate and will serve on various committees upon shareholder approval [1][2] - The specialized committee members have been updated, with Chen Junze taking key roles [4] Group 2: Medical Device Registration - The company’s subsidiary has received medical device registration certificates in China, Australia, and Singapore [3][5] - The new products will expand the company's market reach and enhance its product variety [5] Group 3: Upcoming Shareholder Meeting - The second extraordinary general meeting of shareholders is scheduled for November 20, 2025 [6][10] - The meeting will utilize both on-site and online voting methods [6][8] - Shareholders must register in advance and provide necessary documentation to attend [9][10]